Abstract

(BJOG. 2020;127:1241–1248) Venous thromboembolism (VTE) in pregnant women is commonly prevented using low-molecular weight heparin (LMWH), which does not cross the placenta. Women treated with LMWH often stop treatment for 24 hours prior to planned induction of labor or cesarean delivery to ensure safe neuraxial analgesia. It is unclear, however, how planned induction affects maternal outcomes compared with spontaneous delivery. This study aimed to fill a gap in the literature by comparing planned induction of labor and spontaneous onset of labor in pregnant patients using prophylactic LMWH therapy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.